Functionalized Indolizines as Potential Anticancer Agents: Synthetic, Biological and In Silico Investigations
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178368 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Roxana Ciorteanu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Interdisciplinary Research-RECENT AIR Center, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania. Hauptthemen laut MEDLINE: Indolizines, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Three new series of indolizines (5a–f, 6a–f and 7a–g), functionalized with bromine or ethyl ester substituents on the pyridine ring, were designed and synthesized as promising anticancer agents. The synthesis of indolizine derivatives was carried out using the 1,3-dipolar cycloaddition of pyridinium N-ylides to ethyl propiolate as a key step. Spectral characterization (using NMR, FT-IR, HRMS and X-ray diffraction) showed that two types of cycloadducts 5a–f and 6a–f were obtained when the ylides generated by the 3-bromopyridinium salts were used as 1,3-dipoles in Huisgen cycloaddition reactions to ethyl propiolate. The anticancer effect of selected compounds was in vitro assessed against the National Cancer Institute (NCI) panel of 60 human tumor cells, at 10 μM concentration, with three compounds (5c, 6c and 7g) showing promising inhibitory activity on the growth of several cell lines including lung, brain, renal cancer and melanoma, as well as a cytotoxic effect against HOP-62 non-small cell lung cells (34% for compound 5c and 15% for compound 7g) and SNB-75 glioblastoma cells (15% for compound 5c and 14% for derivative 7c). Molecular docking revealed favorable binding affinities for 5c, 6c and 7g (–9.22 to –9.88 kcal/mol) at the colchicine-binding site of tubulin with key interactions involving βASN-258, βALA-317, and βLYS-352 residues for 5c, βASN-258 in case of 6c, and αVAL-181 and βLYS-254 for derivative 7g. According to the in silico ADMET analysis, the active compounds are predicted to exhibit good oral bioavailability, promising drug-like qualities and low toxicity risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Interdisciplinary Research-RECENT AIR Center, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania.
- Faculty of Chemistry, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania.
- Institute of Interdisciplinary Research-CERNESIM Centre, Alexandru Ioan Cuza University of Iasi, 11 Carol I, 700506 Iasi, Romania.
- Centre of Advanced Research in Bionanoconjugates and Biopolymers, "Petru Poni" Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
- Department of Inorganic Polymers, "Petru Poni" Institute of Macromolecular Chemistry of Romanian Academy, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.
ORCID-Profile: Catalina Ionica Ciobanu, Narcis Cibotariu, Sergiu Shova, Vasilichia Antoci, Ionel I Mangalagiu, Ramona Danac
Zitieren
APA
Ciorteanu, R., Ciobanu, C. I., Cibotariu, N., Shova, S., Antoci, V., Mangalagiu, I. I., & Danac, R. (2025). Functionalized Indolizines as Potential Anticancer Agents: Synthetic, Biological and In Silico Investigations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178368
Vancouver
Ciorteanu R, Ciobanu CI, Cibotariu N, Shova S, Antoci V, Mangalagiu II, et al. Functionalized Indolizines as Potential Anticancer Agents: Synthetic, Biological and In Silico Investigations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178368
BibTeX
@article{Ciorteanu2025,
author = {Ciorteanu, Roxana and Ciobanu, Catalina Ionica and Cibotariu, Narcis and Shova, Sergiu and Antoci, Vasilichia and Mangalagiu, Ionel I and Danac, Ramona},
title = {Functionalized Indolizines as Potential Anticancer Agents: Synthetic, Biological and In Silico Investigations},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178368}
}
EUVIMED